---
layout: single
author_profile: true
title: "Business Trip Report - Korea @ Dec-2025"
date: Mon Jan  5 23:11:48 PST 2026
last_modified_at: Tue Jan  6 01:05:09 PST 2026
permalink: /report/biz-trip/2025/dec
categories:
 - report
tags:
 - business trip
toc: true
toc_label: "&nbsp;Table of Contents"
toc_icon: "fa-solid fa-music"
toc_sticky: true
---

posted: {{ page.date| date: "%d-%b-%Y" }}
&amp;
updated: {{ page.last_modified_at| date: "%d-%b-%Y" }}
{: .notice--primary}

**Report prepared by** Sunghee Yun
<br>
**Initial draft on** 05-Jan-2026
<br>
**Final Revised on** 06-Jan-2026

# Trip Overview

**Korea â€¢ December 9-21, 2025 (12 nights) â€¢ Sunghee Yun**

Conference-intensive 12-night trip anchoring year-end partnerships and government relations. During this trip, Sunghee
- attended **AI-BioX ConfEX Grand Summit 2025** (2-day premier biotech/AI conference)
- formalized **Keimyung University Dongsan Hospital joint development** with ì´ì‹œìš± êµìˆ˜ (MD/Professor/CEO) ê°•í˜œì¸ êµìˆ˜ (MD/Professor, Clinical Laboratory Medicine)
- obtained **strong endorsement from ê¹€ì¤€í˜ ì˜ì›** (National Assembly Member) at SNUBH meeting
- received **SNUBH Head introduction promise** (ì§„ë‹¨ê²€ì‚¬ì˜í•™ê³¼ major)
- secured **ê°€ì²œëŒ€ì˜ëŒ€ (Gachon University College of Medicine) introduction** from ê¹€ìš©ì„ ì›ì¥
- secured **ë‚˜ì€ë³‘ì› (Naeun Hospital, Incheon Songdo) introduction** from ê¹€ì˜ì›… ëŒ€í‘œ
- networked with **50+ biotech/medical/AI professionals** at AI-BioX Conference
- served as **judge for Researchthon** evaluating 10 research teams
- participated in **VIP lunch and Science & Technology Talent Ecosystem Town Hall**
- connected with **Forest Partners** (í™©í˜¸ì—° GP) for investment landscape insights
- advanced **KAIST partnership** discussions with ì„ì±„ê¶Œ êµìˆ˜
- strengthened **LULUMEDIC partnership** through multiple meetings

<!--
- secured **preliminary testing environment (PoC)** from Keimyung for biochip development
-->

# Basic Logistics

**Dates** - December 9-21, 2025 (12 nights)

**Flights**
- **Outbound** - United 893, SFO â†’ ICN (departed Dec 9 @ 10:30am PST, arrived Dec 10 @ 4:15pm KST, 13h)
- **Return** - OZ 212, ICN â†’ SFO (departed Dec 21 @ 8:47pm KST, arrived Dec 21 @ 2:13pm PST, 10h 26m)

**Base** - Suji, Gyeonggi-do

**Regional Trip**
- **Dec 15** - Day trip to Daegu for Keimyung University Dongsan Hospital
  - KTX 072: Gwangmyeong Station â†’ Dongdaegu Station (12:17pm â†’ 1:47pm)
  - KTX 218: Dongdaegu Station â†’ Gwangmyeong Station (7:12pm â†’ 8:46pm)

# ACTION ITEMS

| Owner | Deliverable | Deadline | Status |
|-------|-------------|----------|--------|
| Sunghee Yun / Jin Young Heo | **Execute joint development agreement with Keimyung University Dongsan Hospital** with ê°•í˜œì¸ êµìˆ˜ (Laboratory Medicine) | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Initiate PoC at Keimyung preliminary testing environment** for biochip validation | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Meet SNUBH Head** (ì§„ë‹¨ê²€ì‚¬ì˜í•™ê³¼ major) - arranged by ì‹ ì›ìˆœ/ì¡°ë³‘ì£¼ | Next trip Q1-2026 | <span style="color: blue;">Scheduled</span> |
| Sunghee Yun / Jin Young Heo | **Find and contract CRO for SNUBH IRB process** | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Follow up with ê¹€ì˜ì›… ëŒ€í‘œ** on ë‚˜ì€ë³‘ì› (Naeun Hospital, Incheon Songdo) introduction | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Meet ê°€ì²œëŒ€ì˜ëŒ€** (Gachon University College of Medicine) - introduced by ê¹€ìš©ì„ ì›ì¥ | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Finalize partnership terms with LULUMEDIC** | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Advance collaboration with MaiT** (ì´ì‹œìš± ëŒ€í‘œ, í•œë´‰ì£¼ QA Lead) on technical and commercial fronts | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Follow up with ì„ì±„ê¶Œ êµìˆ˜** (KAIST) on Silicon Valley visit and KAIST-Erudio Bio partnership | Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Engage with í™©í˜¸ì—°** (General Partner, Forest Partners) for potential investment discussions | Q1-2026 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Leverage AI-BioX Conference network** - follow up with key contacts from Johns Hopkins, Cambridge, Cedars-Sinai, SNU, etc. | Q1-2026 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Connect with ê¹€ì¢…ì¼** (Director, SNU Medicine Biochemistry & Molecular Biology) for research collaboration | Q1-2026 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Follow up with í™©ì¬ì„ ** (VP, SK Bioscience Digital Innovation) from Town Hall meeting | Q1-2026 | <span style="color: red;">Pending</span> |

# MILESTONES & TIMELINE

**Immediate (Dec 2025):**
- âœ… AI-BioX ConfEX Grand Summit 2025 participation completed (2 days)
- âœ… Keimyung University Dongsan Hospital joint development formalized with ê°•í˜œì¸ êµìˆ˜
- âœ… Keimyung preliminary testing environment (PoC) secured
- âœ… ê¹€ì¤€í˜ ì˜ì› strong endorsement obtained at SNUBH meeting
- âœ… SNUBH Head meeting arranged for next trip
- âœ… ë‚˜ì€ë³‘ì› introduction secured from ê¹€ì˜ì›… ëŒ€í‘œ
- âœ… ê°€ì²œëŒ€ì˜ëŒ€ introduction secured from ê¹€ìš©ì„ ì›ì¥
- âœ… Researchthon judge participation completed (10 teams evaluated)
- âœ… 50+ biotech/AI professional network expanded
- âœ… Forest Partners investment landscape meeting
- ğŸ”„ CRO search for SNUBH IRB process
- ğŸ”„ Joint development agreement documentation

**Short-term (Q1 2026):**
- Keimyung joint development agreement executed
- PoC initiated at Keimyung preliminary testing environment
- SNUBH Head meeting completed
- CRO contracted for IRB process
- ë‚˜ì€ë³‘ì› partnership discussions initiated
- ê°€ì²œëŒ€ì˜ëŒ€ collaboration explored
- LULUMEDIC partnership finalized
- MaiT technical/commercial collaboration advanced
- KAIST partnership framework defined

**Medium-term (2026):**
- Four hospital partnerships operational (SNUBH, Seoul Asan, Keimyung, ë‚˜ì€ë³‘ì›/ê°€ì²œëŒ€)
- IRB approvals progressing through CRO support
- Keimyung PoC results validating technology
- Clinical data generation from multiple hospital sites
- National Assembly support leveraged for regulatory advantages
- Investment secured through expanded investor network

# STRATEGIC INSIGHTS

1. **Four-Hospital Network Strategy Crystallizing:**
   - **SNUBH** (Seoul National University Bundang Hospital) - IRB in progress, National Assembly support
   - **Seoul Asan Hospital** - Asan Foundation (ê¹€ì¸ì¬) ready when timing appropriate
   - **Keimyung University Dongsan Hospital** - Joint development formalized, PoC environment secured
   - **ë‚˜ì€ë³‘ì›** (Naeun Hospital, Incheon Songdo) - Introduction by ê¹€ì˜ì›…, pending engagement
   - **ê°€ì²œëŒ€ì˜ëŒ€** (Gachon University College of Medicine) - Introduction by ê¹€ìš©ì„, pending engagement
   - Geographic diversity (Seoul, Bundang, Daegu, Incheon) + institutional variety (national university, private hospital, medical school) creates robust validation network

2. **National Assembly Endorsement - Political Capital:**
   - ê¹€ì¤€í˜ ì˜ì› (Deputy Floor Leader, Democratic Party) stated "utmost confidence" in Erudio Bio's technology, marketability, product value, profitability
   - Direct quote: "understood our technology and would help us in whatever way he could"
   - Meeting at SNUBH demonstrates political support at clinical collaboration site
   - Complements Suwon íŠ¹êµ¬ invitation from same ì˜ì› (Nov trip)
   - National Assembly endorsement provides regulatory advantages and government funding access

3. **Keimyung PoC Environment - De-Risking Technology:**
   - Preliminary testing environment offered before full joint development execution
   - PoC phase allows technology validation with minimal resource commitment
   - De-risks partnership for both sides
   - Success in PoC creates momentum for expanded collaboration
   - ê°•í˜œì¸ êµìˆ˜ (Laboratory Medicine) engagement fulfills Nov promise from ì´ì‹œìš± ëŒ€í‘œ

4. **AI-BioX Conference - Ecosystem Integration:**
   - Premier 2-day conference with 50+ high-quality contacts
   - **International reach** - Johns Hopkins (ê¹€ë•í˜¸), Cambridge (í•œë‚¨ì‹), Cedars-Sinai (ì›ê²½ì¬)
   - **Domestic institutions** - SNU Medicine, Korea University, ê±´êµ­ëŒ€, ê´‘ìš´ëŒ€, ì¶©ë‚¨ëŒ€, ë™êµ­ëŒ€
   - **Industry** - SK Bioscience (í™©ì¬ì„ ), ë°±ìŠ¤ë‹¤ì„, ì˜¤ê°€ë…¸í”ŒëŸ¬ìŠ¤, LSK Investment
   - **Government** - National Assembly (ì´í•´ë¯¼ ì˜ì›, ê¹€ë‚¨í¬ ì˜ì›), Suwon City (ê¹€ì§€ì˜, ê¹€ì„±ì§„, í™©ì¸ìˆ˜)
   - VIP lunch, Town Hall participation, Researchthon judge role = thought leader positioning

5. **CRO Strategy - IRB Process Acceleration:**
   - Dec 13 dinner decision to find/contract CRO for SNUBH IRB
   - Professional CRO support accelerates regulatory approval
   - Expertise in MFDS/KFDA processes critical for biochip medical equipment category
   - Reduces burden on internal team
   - Multiple hospital IRBs will benefit from CRO expertise

6. **Hospital Introduction Chain Reaction:**
   - ê¹€ì˜ì›… ëŒ€í‘œ introducing ë‚˜ì€ë³‘ì› (after multiple LULUMEDIC meetings across trips)
   - ê¹€ìš©ì„ ì›ì¥ introducing ê°€ì²œëŒ€ì˜ëŒ€ (after single lunch meeting)
   - Each hospital partnership creates credibility for next introduction
   - Network effects accelerating - easier to get introductions as validation grows
   - Hospital administrators/professors see peer institutions engaging with Erudio Bio

7. **SNUBH Head Meeting - Institutional Commitment Signal:**
   - SNUBH Head has ì§„ë‹¨ê²€ì‚¬ì˜í•™ê³¼ major (Laboratory Medicine background)
   - Perfect alignment with Erudio Bio's diagnostic focus
   - Head-level meeting indicates institutional (not just professor) commitment
   - Meeting arranged by ì‹ ì›ìˆœ (ì •ì±…êµ­ì¥) and ì¡°ë³‘ì£¼ (ì—°êµ¬í–‰ì •íŒ€ì¥) - administrative leadership
   - Institutional support critical for sustained collaboration beyond individual professors

8. **Researchthon Judge Role - Thought Leadership:**
   - Evaluated 10 research teams in biotech/medical science/AI
   - Judge role positions Sunghee as expert evaluator (not just participant)
   - Mentoring students at finale dinner extends influence to next generation
   - Students remember judges who provided valuable feedback
   - Talent pipeline for future hiring as Erudio Bio scales

9. **Science & Technology Talent Ecosystem Town Hall:**
   - Participated alongside SK Bioscience VP (í™©ì¬ì„ ), ê´‘ìš´ëŒ€ Graduate School Dean (ê¹€ë‚¨ì˜), KAIST Professor (ì •ì¬ìŠ¹)
   - Town Hall format = policy/strategy level (not just technical)
   - Positions Sunghee as ecosystem builder, not just company founder
   - Government/industry/academia representation in Town Hall = triple helix model
   - Insights into Korea's talent development strategy inform Erudio Bio hiring

10. **Investment Landscape Intelligence:**
    - í™©í˜¸ì—° (General Partner, Forest Partners) meeting
    - Bio investment landscape insights critical for fundraising strategy
    - Understanding investor perspectives before Series A pitch
    - Forest Partners potential investor for future rounds
    - Investment network expanding beyond angels to institutional VCs

11. **KAIST Partnership Momentum:**
    - ì„ì±„ê¶Œ êµìˆ˜ (Visiting Professor/Full Professor, EE, KAIST)
    - Discussed Silicon Valley visit - potential for US-Korea collaboration model
    - Complements ë°°í˜„ë¯¼ (KAIST Startup Center Director) connection from Nov
    - Multiple KAIST touchpoints (professor + startup center) = institutional relationship
    - KAIST technical credibility valuable for technology validation

12. **MaiT Commercial Partnership Evolution:**
    - Beyond just clinical collaboration (Keimyung hospital partnership)
    - Discussing technical collaboration for Erudio Bio products with MaiT Health
    - MaiT as commercial partner could provide distribution/commercialization pathway
    - ì´ì‹œìš± ëŒ€í‘œ's dual role (hospital + company) creates synergies
    - í•œë´‰ì£¼ (QA Lead) involvement indicates serious product development discussions

13. **Seoul Science High School Network Continuous Investment:**
    - ì„¤ê³½ì¸ì˜ ë°¤ (annual SSHS alumni event) attendance
    - Alumni network provides long-term support across multiple dimensions
    - SSHS alumni in government, industry, academia, finance
    - Regular participation maintains visibility and access
    - Previous sponsorship (Nov trip) + annual event = comprehensive engagement

14. **Year-End Timing Strategic:**
    - December trip allows year-end relationship maintenance before 2026 acceleration
    - Conference attendance in December captures professionals before holidays
    - Hospital partnerships formalized before new year planning cycles
    - Investment discussions seeded for Q1 2026 fundraising
    - Momentum maintained through holiday period

15. **Multi-Hospital Collaboration Model Validation:**
    - SNUBH model (joint development + IRB + cancer biomarkers) now template
    - Keimyung adopting same model but exploring different biomarkers
    - Demonstrates scalability - can replicate successful model across institutions
    - Different biomarkers per hospital reduces competition, enables cooperation
    - Multi-site validation strengthens MFDS approval case

# KEY MEETINGS & OUTCOMES

## 10-Dec-2025 - Arrival & AI-BioX Pre-Conference

### 4:15pm - Arrival at ICN

### Evening - AI-BioX ConfEX Pre-Conference Networking Dinner

<h4>Location</h4>

ë§ˆë…¸ë””ì…°í”„ ì‚¼ì„±ì  (Mano di Chef Samsung Branch)
ì„œìš¸ ê°•ë‚¨êµ¬ í…Œí—¤ë€ë¡œ87ê¸¸ 21 ë™ì„±ë¹Œë”© B1ì¸µ

<h4>Key Attendees</h4>

- Sunghee Yun
- **ê¹€ë•í˜¸ êµìˆ˜** (Professor and Director, Department of Biomedical Engineering / Center for Microphysiological Systems, Johns Hopkins Medicine)
- **ì‹ ì¬ì˜ ëŒ€í‘œ** (CEO, OrganoPlus)
- **ì›ê²½ì¬ êµìˆ˜** (Associate Professor, Department of Computational Biomedicine, Cedars-Sinai Medical Center)
- **ì´ì‹œì—° ë°•ì‚¬** (K-BioX Representative Operating Committee Member, Stanford Medical School, K-BioX)
- **ì´í•´ë¯¼ ì˜ì›** (National Assembly Member)
- **ìµœê¸°ì£¼ ì´ì¥** (President, Ajou University)
- **í™íšŒì§„ ëŒ€í‘œì´ì‚¬** (CEO, EcoMice)

<h4>Outcomes</h4>

High-level networking with international institutions (Johns Hopkins, Cedars-Sinai), K-BioX leadership, National Assembly, and university presidents

---

## 11-Dec-2025 - AI-BioX ConfEX Grand Summit Day 1

### 9am-5pm - Full Day Conference Attendance & Networking

<h4>Event</h4>

AI-BioX ConfEX Grand Summit 2025
Website: https://www.ai-biox.com/

<h4>Key Contacts Established (30+ attendees)</h4>

**International Academia:**
- Ahmed Morsy Abdal Dayem (Assistant Professor, Department of Stem Cell & Regenerative Biotechnology, Konkuk University)
- í•œë‚¨ì‹ êµìˆ˜ (Professor / Ph.D., Milner Therapeutics Institute / Cambridge Centre for AI in Medicine / Cambridge Stem Cell Institute, University of Cambridge)
- ê¹€íƒœí˜• (Ph.D. / Assistant Professor, Department of Pathology, UNM Health Sciences Center / Cancer Research Facility)

**Domestic Academia:**
- ê¹€ë‚¨ì˜ êµìˆ˜ (Professor / Graduate School Dean, Department of Electronic Engineering, Kwangwoon University)
- ê¹€ì¢…ì¼ (Director / Department Chair / Professor / Center Director, College of Medicine / Department of Biochemistry & Molecular Biology / Department of Medical Science, SNU Medicine)
- ê¹€ì¸ìˆ˜ (Assistant Professor, Department of Pharmacology / College of Medicine, Chungnam National University)
- ì¡°ìŒêµ¬ êµìˆ˜ (Professor / Center Director / Department Chair, Department of Stem Cell & Regenerative Engineering / College of Advanced Bioengineering / Molecular Cellular Reprogramming Center, Konkuk University)
- ì¥ì„œì˜ (Research Professor, Department of Life Science, Dongguk University)
- ìµœí˜•ì§„ êµìˆ˜ (Professor / Internal Medicine Specialist / Endocrinology-Metabolism Specialist, Department of Brain and Cognitive Sciences / Department of Anatomy / Department of Medical Science, Seoul National University)

**Industry - Biotech/Pharma:**
- ê¶Œí˜„ì • (Director, Business Planning Team, OrganoPlus)
- ê¹€ì€ì„± ëŒ€í‘œ (CEO / CTO, Kims Bio Lab)
- ê¹€ìš©ì„± (Senior Researcher, Development Division, Vaxdyme)
- ì˜¤ë¬¸ì£¼ (Research Director / CTO, GD CORP.)
- ì§„ë™í™˜ ëŒ€í‘œì´ì‚¬ (CEO, MyMeta)
- í™ì„±í˜„ ëŒ€í‘œì´ì‚¬ (CEO, Clichembio)
- ì„œì •í•œ (Business Leader, Genome Analysis Team, Rokit Genomics)

**Industry - Investment/Strategy:**
- í•œìƒì—½ ë¶€ì‚¬ì¥ (Vice President, LSK Investment)
- í™©ì¬ì„  ë¶€ì‚¬ì¥ (Vice President, SK Bioscience Digital Innovation Office, SK Discovery)
- í™©ì£¼ì˜ ìƒë¬´ (Executive Director, Strategic Planning Division, Revomed)

**Government/Institutional:**
- ê¹€ë‚¨í¬ ì˜ì› (National Assembly Member)
- ê¹€ì„±ì§„ íŒ€ì¥ (Team Leader, Economic Free Zone Promotion Team, Suwon City Hall)
- ê¹€ì§€ì˜ (Team Leader, Advanced Industry Promotion Team, Economic Free Zone Promotion Team, Suwon City Hall)
- í™©ì¸ìˆ˜ (Official, Economic Free Zone Promotion Team / Advanced Industry Promotion Team, Suwon City Hall)
- ê¹€ì£¼ì—° íŒ€ì¥ (Team Leader, R&D Business Division / Commercialization Support Team, Korea Drug Development Fund)
- ì´ìœ¤ë¯¸ (Principal Researcher, R&D Business Division / Commercialization Support Team, Korea Drug Development Fund)

**Medical Institutions:**
- ë°•í—Œì¤€ (Medical Research Office Technology Business Team / Medical Center Industry-Academic Cooperation Foundation Technology Business Team / Korea University Medical Technology Holding Company, Korea University Medical Center)

**Media:**
- ì„œì¼ ê¸°ì (Journalist, Editorial Department, BioSpectator)

**Event Management:**
- ê¹€ì†Œìœ¤ (Assistant Manager, MICE Business Division, EcoMice)
- ì´ì¬êµ­ íŒ€ì¥ (Team Leader, MICE Business Division, EcoMice)

<h4>Learning Outcomes</h4>

- Attended presentations on biotech, medical sciences, and AI integration
- Gained insights across stem cell research, drug discovery, computational biomedicine
- Expanded network with Cambridge, Johns Hopkins, SNU, industry leaders

### 12pm-1pm - VIP Lunch

<h4>Format</h4>

Exclusive VIP lunch for conference speakers and distinguished guests

### 6pm-8pm - Networking Dinner - Korea University Medicine

<h4>Attendees</h4>

- Sunghee Yun
- ê³ ì¬ì²  êµìˆ˜ (Professor / M.D., Department of Pain Medicine, Korea University College of Medicine)
- ë°•ì¬ìš± (Technology Transfer Office, Korea University Medicine)

<h4>Purpose</h4>

Networking with MDs and exploring technology transfer opportunities at Korea University

---

## 12-Dec-2025 - AI-BioX ConfEX Grand Summit Day 2 (Final Day)

### 10am-11:20am - Science & Technology Talent Ecosystem Town Hall Meeting

<h4>Participants</h4>

- Sunghee Yun
- í™©ì¬ì„  ë¶€ì‚¬ì¥ (Vice President, SK Bioscience Digital Innovation Office, SK Discovery)
- ê¹€ë‚¨ì˜ êµìˆ˜ (Professor / Graduate School Dean, Department of Electronic Engineering, Kwangwoon University)
- ì •ì¬ìŠ¹ êµìˆ˜ (Professor, KAIST)

<h4>Discussion Topics</h4>

Korea's science and technology talent ecosystem - education, industry needs, policy frameworks

<h4>Outcome</h4>

Positioned alongside industry (SK), academia (KAIST, Kwangwoon), and government representatives as ecosystem thought leader

### 1pm-3pm - Researchthon Judge

<h4>Role</h4>

Judge for conference Researchthon competition

<h4>Responsibility</h4>

Evaluated 10 research teams presenting results in biotech, medical science, and AI

<h4>Outcome</h4>

- Thought leadership positioning as expert evaluator
- Exposure to cutting-edge research from multiple teams
- Network expansion with participating researchers

### 6pm-8pm - Conference Finale Dinner & Student Mentoring

<h4>Activity</h4>

Invited to finale dinner where Sunghee mentored numerous students

<h4>Outcome</h4>

Extended influence to next generation, created talent pipeline for future

---

## 13-Dec-2025 - Strategy Session with Jin Young Heo

### 7pm-9pm - Dinner - Erudio Bio Korea Strategy Discussion

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)

<h4>CRITICAL DECISIONS MADE</h4>

- **CRO Search** - find and contract Clinical Research Organization (CRO) for SNUBH IRB process
- **Daegu Trip Planning** - plan Dec 15 visit to Keimyung University Dongsan Hospital to initiate joint development similar to SNUBH model
- **LULUMEDIC Partnership** - advance partnership discussions with ê¹€ì˜ì›… ëŒ€í‘œ

<h4>Strategic Impact</h4>

CRO decision accelerates IRB approval process across multiple hospital partnerships

---

## 14-Dec-2025 - LULUMEDIC Partnership & Hospital Introduction

### 9am-11am - Brunch with LULUMEDIC

<h4>Attendees</h4>

- Sunghee Yun
- ê¹€ì˜ì›… ëŒ€í‘œ (President, Korea Digital Health Industry Association / CEO, LULUMEDIC)

<h4>Discussion</h4>

Potential partnership between Erudio Bio and LULUMEDIC

<h4>CRITICAL OUTCOME</h4>

**ê¹€ì˜ì›… ëŒ€í‘œ proposed to introduce ì¸ì²œì†¡ë„ ë‚˜ì€ë³‘ì› (Naeun Hospital, Incheon Songdo) for similar partnership model as SNUBH**

<h4>Strategic Impact</h4>

Fourth hospital partnership track opened - Naeun Hospital in strategic Incheon Songdo location

---

## 15-Dec-2025 - Keimyung University Dongsan Hospital - PARTNERSHIP FORMALIZATION

### 12:17pm-1:47pm - Travel to Daegu

KTX 072: Gwangmyeong Station â†’ Dongdaegu Station
Travelers: Sunghee Yun, Jin Young Heo

### 3pm-5pm - Joint Development Partnership Meeting - BREAKTHROUGH

<h4>Location</h4>

Keimyung University Dongsan Hospital, Daegu

<h4>Attendees</h4>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
- **ì´ì‹œìš± ëŒ€í‘œì´ì‚¬** (CEO, MaiT / M.D. / Professor, Keimyung University Dongsan Hospital)
- **ê¹€ë„í›ˆ ì£¼ì„êµìˆ˜** (Chief Professor, Department of Laboratory Medicine, Keimyung University)
- **ê°•í˜œì¸ êµìˆ˜** (Professor, Department of Laboratory Medicine, Keimyung University)

<h4>CRITICAL DECISIONS & OUTCOMES</h4>

- **Joint development agreement** - formalized partnership for biochip medical equipment development for multiplexing cancer biomarker detection (same model as SNUBH)
- **Biomarker differentiation** - agreed to explore different biomarkers than SNUBH to avoid overlap and enable collaboration
- **PoC environment offered** - Keimyung proposed providing **preliminary testing environment for Proof of Concept**
- **Laboratory Medicine expertise** - ê¹€ë„í›ˆ (Chief Professor) and ê°•í˜œì¸ (Professor) engagement ensures clinical expertise

<h4>Strategic Impact - MAJOR MILESTONE</h4>

- Third major hospital partnership formalized (SNUBH, Seoul Asan on track, Keimyung)
- PoC environment de-risks technology validation
- Different biomarkers per hospital creates collaborative rather than competitive network
- Fulfills November promise from ì´ì‹œìš± to introduce ê°•í˜œì¸ êµìˆ˜
- Daegu regional presence solidified

### 7:12pm-8:46pm - Return to Seoul Area

KTX 218: Dongdaegu Station â†’ Gwangmyeong Station
Travelers: Sunghee Yun, Jin Young Heo

---

## 18-Dec-2025 - KAIST Partnership & SNUBH Political Support

### 12pm-1:30pm - Lunch with KAIST Faculty

<h4>Attendees</h4>

- Sunghee Yun
- ì„ì±„ê¶Œ êµìˆ˜ (Visiting Professor (Full Professor) / Ph.D. Engineering / Ph.D. Science & Technology Policy, School of Electrical and Electronic Engineering, Korea Advanced Institute of Science and Technology)

<h4>Discussion Topics</h4>

- ì„ì±„ê¶Œ êµìˆ˜'s upcoming Silicon Valley visit
- Potential partnership between Erudio Bio and KAIST
- US-Korea collaboration models

<h4>Outcome</h4>

KAIST partnership discussions advanced - complements ë°°í˜„ë¯¼ (Startup Center Director) connection

### 4:30pm-6pm - SNUBH Meeting - NATIONAL ASSEMBLY ENDORSEMENT

<h4>Location</h4>

Seoul National University Bundang Hospital (SNUBH)

<h4>Attendees</h4>

- Sunghee Yun
- **ê¹€ì¤€í˜ ì˜ì›** (National Assembly Member / Deputy Floor Leader, Democratic Party)
- **ì‹ ì›ìˆœ** (Policy Director, Seoul National University Bundang Hospital)
- **ì¡°ë³‘ì£¼** (Research Administration Team Leader, Seoul National University Bundang Hospital)
- í™ì°½ë¯¼ ëŒ€í‘œì´ì‚¬ (CEO, Animoby)

<h4>Sunghee's Presentation</h4>

- Working with ì´ê¸°í—Œ êµìˆ˜ and team on joint development
- Currently under IRB process
- Developing biochip medical equipment for multiplexing cancer biomarker detection
- Targeting health checkup centers

<h4>CRITICAL OUTCOMES</h4>

- **Strong political endorsement** - ê¹€ì¤€í˜ ì˜ì› stated he "understood our technology" and "would help us in whatever way he could"
- **Confidence statement** - ì˜ì› expressed "utmost confidence in our technology and marketability, product values, profitability, etc."
- **SNUBH Head meeting arranged** - ì‹ ì›ìˆœ/ì¡°ë³‘ì£¼ will arrange meeting with SNUBH Head for next trip
- **SNUBH Head background** - Head's major is ì§„ë‹¨ê²€ì‚¬ì˜í•™ê³¼ (Laboratory Medicine) - perfect alignment
- **Stakeholder network created** - connected with hospital administrative leadership

<h4>Strategic Impact</h4>

National Assembly Member endorsement at hospital site demonstrates high-level political support for clinical collaboration

---

## 19-Dec-2025 - MaiT Partnership & Alumni Network

### 5:15pm-6:45pm - Dinner with MaiT Leadership

<h4>Attendees</h4>

- Sunghee Yun
- ì´ì‹œìš± ëŒ€í‘œì´ì‚¬ (CEO, MaiT / M.D. / Professor, Keimyung University Dongsan Hospital)
- í•œë´‰ì£¼ (QA Lead, MaiT)

<h4>Discussion Topics</h4>

- How to proceed with Erudio Bio - Keimyung University Dongsan Hospital collaboration
- Technical collaboration for Erudio Bio products with MaiT Health

<h4>Outcome</h4>

- Keimyung collaboration execution path clarified
- MaiT product collaboration framework discussed
- Dual clinical + commercial partnership model advancing

### 7pm-9pm - ì„¤ê³½ì¸ì˜ ë°¤ (Seoul Science High School Alumni Event)

<h4>Event</h4>

ì„¤ê³½ì¸ì˜ ë°¤ - Annual Seoul Science High School (SSHS) alumni gathering

<h4>Purpose</h4>

Strengthen general network with SSHS alumni across government, industry, academia, finance

<h4>Outcome</h4>

Maintained long-term alumni relationships for sustained support network

---

## 20-Dec-2025 - University & Investment Network Expansion

### 12pm-1pm - Lunch - GACHON UNIVERSITY INTRODUCTION

<h4>Attendee</h4>

- Sunghee Yun
- ê¹€ìš©ì„ ì›ì¥ (Dean, Graduate School of Semiconductor, Gachon University)

<h4>Sunghee's Presentation</h4>

- Erudio Bio, Inc. overview
- Gates Foundation Award
- SNUBH collaboration
- Keimyung University Dongsan Hospital collaboration

<h4>CRITICAL OUTCOME</h4>

**ê¹€ìš©ì„ ì›ì¥ proposed to introduce ê°€ì²œëŒ€ì˜ëŒ€ (Gachon University College of Medicine)!**

<h4>Strategic Impact</h4>

Fifth hospital/medical school partnership track opened - Gachon University adds institutional diversity

### 4pm-5pm - Coffee Chat with Forest Partners

<h4>Attendee</h4>

- Sunghee Yun
- í™©í˜¸ì—° (General Partner, Forest Partners)

<h4>Purpose</h4>

- Learn about bio investment landscape
- Build network for potential investment in Erudio Bio

<h4>Outcome</h4>

- Gained investment landscape intelligence
- Positioned Erudio Bio for future institutional VC funding
- Forest Partners potential investor for Series A or later rounds

---

# FUNDRAISING

## Investment Landscape Intelligence

**Contact** - í™©í˜¸ì—° (General Partner, Forest Partners)

**Outcome** - Bio investment landscape insights, potential investor for future rounds

**Timeline** - Dec 20, 2025 coffee meeting

**Status** - <span style="color: red;">**Initial meeting, relationship building for future funding rounds**</span>

## National Assembly Political Support

**Contact** - ê¹€ì¤€í˜ ì˜ì› (National Assembly Member / Deputy Floor Leader)

**Value** - Political endorsement provides regulatory advantages and government funding access

**Status** - <span style="color: green;">**Strong endorsement obtained, active support promised**</span>

# PARTNERSHIP

## Keimyung University Dongsan Hospital - FORMALIZED

**Contacts**
- ì´ì‹œìš± ëŒ€í‘œì´ì‚¬ (CEO, MaiT / M.D. / Professor)
- ê°•í˜œì¸ êµìˆ˜ (Professor, Laboratory Medicine)
- ê¹€ë„í›ˆ ì£¼ì„êµìˆ˜ (Chief Professor, Laboratory Medicine)

**Outcome** - Joint development partnership formalized, PoC environment secured

**Status** - <span style="color: blue;">**Partnership formalized, executing agreement**</span>

## MaiT (Commercial Partnership)

**Contacts**
- ì´ì‹œìš± ëŒ€í‘œì´ì‚¬ (CEO)
- í•œë´‰ì£¼ (QA Lead)

**Scope** - Technical collaboration for Erudio Bio products, commercial pathway

**Status** - <span style="color: blue;">**Active discussions, framework advancing**</span>

## SNUBH (Seoul National University Bundang Hospital) - INSTITUTIONAL SUPPORT

**Administrative Leadership**
- ì‹ ì›ìˆœ (Policy Director)
- ì¡°ë³‘ì£¼ (Research Administration Team Leader)

**Political Support**
- ê¹€ì¤€í˜ ì˜ì› (National Assembly Member)

**Next Step** - Meeting with SNUBH Head (ì§„ë‹¨ê²€ì‚¬ì˜í•™ê³¼ major)

**Status** - <span style="color: blue;">**IRB in progress, institutional support strengthened, Head meeting scheduled**</span>

## ë‚˜ì€ë³‘ì› (Naeun Hospital, Incheon Songdo) - NEW INTRODUCTION

**Introduced by** - ê¹€ì˜ì›… ëŒ€í‘œ (CEO, LULUMEDIC)

**Location** - Incheon Songdo (strategic Incheon Free Economic Zone location)

**Status** - <span style="color: blue;">**Introduction secured, initial contact pending**</span>

## ê°€ì²œëŒ€ì˜ëŒ€ (Gachon University College of Medicine) - NEW INTRODUCTION

**Introduced by** - ê¹€ìš©ì„ ì›ì¥ (Dean, Graduate School of Semiconductor, Gachon University)

**Status** - <span style="color: blue;">**Introduction secured, initial contact pending**</span>

## LULUMEDIC & Korea Digital Health Industry Association

**Contact** - ê¹€ì˜ì›… ëŒ€í‘œ (President, Korea Digital Health Industry Association / CEO, LULUMEDIC)

**Status** - <span style="color: blue;">**Partnership advancing, finalizing terms**</span>

## KAIST

**Contacts**
- ì„ì±„ê¶Œ êµìˆ˜ (Visiting Professor, EE)
- ë°°í˜„ë¯¼ (Director, KAIST Startup Center / CEO, KAIST Holdings / Professor)

**Status** - <span style="color: blue;">**Multiple touchpoints, partnership framework developing**</span>

# NETWORKING

## AI-BioX ConfEX Grand Summit 2025

**Scale** - 50+ contacts over 2-day conference

**International Institutions**
- Johns Hopkins Medicine (ê¹€ë•í˜¸ êµìˆ˜)
- University of Cambridge (í•œë‚¨ì‹ êµìˆ˜)
- Cedars-Sinai Medical Center (ì›ê²½ì¬ êµìˆ˜)
- UNM Health Sciences Center (ê¹€íƒœí˜•)

**Domestic Universities**
- Seoul National University (ê¹€ì¢…ì¼, ìµœí˜•ì§„)
- Korea University (ê³ ì¬ì² , ë°•ì¬ìš±)
- KAIST (ì •ì¬ìŠ¹)
- Konkuk University (Ahmed Morsy, ì¡°ìŒêµ¬)
- Kwangwoon University (ê¹€ë‚¨ì˜)
- Chungnam National University (ê¹€ì¸ìˆ˜)
- Dongguk University (ì¥ì„œì˜)

**Industry - Biotech/Pharma**
- OrganoPlus (ì‹ ì¬ì˜, ê¶Œí˜„ì •)
- Vaxdyme (ê¹€ìš©ì„±)
- Kims Bio Lab (ê¹€ì€ì„±)
- GD CORP (ì˜¤ë¬¸ì£¼)
- MyMeta (ì§„ë™í™˜)
- Clichembio (í™ì„±í˜„)
- Rokit Genomics (ì„œì •í•œ)

**Industry - Corporate**
- SK Bioscience/SK Discovery (í™©ì¬ì„ )
- LSK Investment (í•œìƒì—½)
- Revomed (í™©ì£¼ì˜)

**Government**
- National Assembly (ì´í•´ë¯¼ ì˜ì›, ê¹€ë‚¨í¬ ì˜ì›, ê¹€ì¤€í˜ ì˜ì›)
- Suwon City Hall (ê¹€ì§€ì˜, ê¹€ì„±ì§„, í™©ì¸ìˆ˜)
- Korea Drug Development Fund (ê¹€ì£¼ì—°, ì´ìœ¤ë¯¸)

**Media**
- BioSpectator (ì„œì¼ ê¸°ì)

## Gachon University

**Contact** - ê¹€ìš©ì„ ì›ì¥ (Dean, Graduate School of Semiconductor)

**Outcome** - ê°€ì²œëŒ€ì˜ëŒ€ introduction secured

## Forest Partners

**Contact** - í™©í˜¸ì—° (General Partner)

**Focus** - Bio investment landscape, potential institutional VC investor

## Korea University Medicine

**Contacts**
- ê³ ì¬ì²  êµìˆ˜ (Professor, Pain Medicine)
- ë°•ì¬ìš± (Technology Transfer Office)

**Focus** - Medical AI collaboration, technology transfer

## Seoul Science High School Alumni

**Event** - ì„¤ê³½ì¸ì˜ ë°¤ (annual alumni gathering)

**Network** - Alumni across government, industry, academia, finance

## EcoMice (Event Management)

**Contact** - í™íšŒì§„ ëŒ€í‘œì´ì‚¬ (CEO)

**Connection** - AI-BioX conference organizer, potential for future events

## Ajou University

**Contact** - ìµœê¸°ì£¼ ì´ì¥ (President)

**Source** - AI-BioX pre-conference dinner
